Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
41.15
+0.95 (2.36%)
Aug 13, 2025, 4:00 PM - Market closed

AAPG Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for AAPG.

Price Target: $0.00 (0.00%)
Analyst Consensus: Buy
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for AAPG is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '25Aug '25
Strong Buy 00
Buy 11
Hold 00
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Buy
Initiates
n/a
Buy Initiates n/a n/a Mar 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
541.62M
from 980.65M
Decreased by -44.77%
Revenue Next Year
2.73B
from 541.62M
Increased by 404.41%
EPS This Year
-3.10
from -1.34
EPS Next Year
2.33
from -3.10
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
12.45M27.91M209.71M221.98M980.65M541.62M2.73B1.77B
Revenue Growth
-14.22%124.18%651.38%5.85%341.77%-44.77%404.41%-35.07%
EPS
-3.14-3.07-3.35-3.28-1.34-3.102.33-0.05
EPS Growth
--------
Forward PE
------17.64-
No. Analysts
-----11116
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 653.1M 3.4B 2.9B
Avg 541.6M 2.7B 1.8B
Low 414.5M 1.8B 758.9M

Revenue Growth

Revenue Growth 20252026202720282029
High
-33.4%
523.3%
7.7%
Avg
-44.8%
404.4%
-35.1%
Low
-57.7%
230.1%
-72.2%

EPS Forecast

EPS 202520262027
High -2.27 4.34 3.15
Avg -3.10 2.33 -0.05
Low -3.92 -0.90 -1.62

EPS Growth

EPS Growth 202520262027
High - -
35.1%
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.